Search This Blog

Friday, January 10, 2020

Biofrontera reports preliminary Q4 and FY 2019 sales

Biofrontera AG (NASDAQ:BFRAreports preliminary Q4 and FY 2019 results.
FY 2019 turnover was between €31.1M and €31.4M.
U.S. product sales are expected to be around €23.3M.
In Germany, FY 2019 product sales will amount to approx. €4.6M, compared with €3.3M for FY 2018.
Q4 sales amounted to ~€12.2M, compared to €6.6M in the previous year.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.